These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39006360)

  • 1. Effect of the degree of follicular diameter ≥18mm differentiation on the day of hCG administration to the outcome of controlled ovarian hyperstimulation (COH).
    Xu H; Chen Q; Tian J; Chen X; Zhang X; Li X; Wu Y; Zhang C; Zhang Y
    Front Endocrinol (Lausanne); 2024; 15():1414213. PubMed ID: 39006360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of time of recombinant luteinized hormone supplementation on pregnancy outcomes of women with advanced reproductive age during follicular-phase long protocol].
    Wang L; Wang J; Hu YQ; Liu JY; Diao FY
    Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):758-766. PubMed ID: 36299179
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual Trigger for Final Follicular Maturation Improves Cumulative Live-Birth Rate in Ovarian Stimulation for Freeze-All
    Zhu H; Zhao C; Pan Y; Zhou H; Jin X; Xu W; Zhang S
    Front Endocrinol (Lausanne); 2021; 12():708247. PubMed ID: 34349729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial.
    Anaya Y; Cakmak H; Mata DA; Letourneau J; Zhang L; Lenhart N; Juarez-Hernandez F; Jalalian L; Cedars MI; Rosen M
    Fertil Steril; 2022 Aug; 118(2):266-278. PubMed ID: 35705380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
    Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
    J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
    Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.
    Hu X; Luo Y; Huang K; Li Y; Xu Y; Zhou C; Mai Q
    Medicine (Baltimore); 2016 May; 95(20):e3691. PubMed ID: 27196479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of follicular size on clinical outcomes of frozen-thawed embryo transfer induced by hCG on ovulation in natural cycles].
    Lu FF; Sun YX; Shi QQ; Jiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 Feb; 58(2):105-111. PubMed ID: 36776005
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
    Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
    Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.
    Lin HY; Li Y; Wang WJ; Qiu Q; Zhang QX; Li Y
    Chin Med J (Engl); 2019 Jun; 132(12):1448-1453. PubMed ID: 31205103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
    Martins WP; Vieira AD; Figueiredo JB; Nastri CO
    Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High progesterone levels on the day after HCG injection has no effect on clinical pregnancy outcomes in
    Liang Z; Huang Q; Huang J; Wu J; Zeng D; Huang P
    Front Endocrinol (Lausanne); 2024; 15():1372753. PubMed ID: 38689731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment.
    Zhang XQ; Zhang LJ; Zhu XL; Xu H; Luo YQ; Yao L; Huang QW; Nong YQ; Liu WJ; Liu FH
    Drug Des Devel Ther; 2021; 15():3573-3580. PubMed ID: 34429586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.